Rachel West

Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial

Cyriel Y. Ponsioen, E. Joline de Groof, Emma J. Eshuis et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 334 citations

Terminal Ileitis, Gastroenterology, Multicentre Trial +4

Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: a double‐blind placebo‐controlled study

Rachel West, C. Janneke van der Woude, Bettina E. Hansen et al. · Alimentary Pharmacology & Therapeutics · 2004 · 247 citations

Immunogenicity negatively influences the outcome of adalimumab treatment in Crohn’s disease

Rachel West, Zuzana Zelinková, Gertjan Wolbink et al. · Alimentary Pharmacology & Therapeutics · 2008 · 210 citations · Full text

Long term results of pneumatic dilation in achalasia followed for more than 5 years

Rachel West, David P. Hirsch, J. F. W. M. Bartelsman et al. · The American Journal of Gastroenterology · 2002 · 206 citations

Esophageal Cancer, Medicine, Symptomatic Treatment +7

Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial

Toer Stevens, Maria L. Haasnoot, Geert D’Haens et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 173 citations

Terminal Ileitis, Medicine, C Trial +5